Apr 12, 2021 / 12:00PM GMT
Operator
Greetings, and welcome to Taysha Gene Therapy's GAN Program Acquisition Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded today, April 12, 2021.
I will now turn the call over to Dr. Kimberly Lee, Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Kimberly Lee - Taysha Gene Therapies, Inc. - SVP of Corporate Communications & IR
Thank you. Good morning, and welcome to Taysha's GAN Program Acquisition Conference Call. Joining me on today's call are RA Session II, Taysha's President, CEO and Founder; and Dr. Suyash Prasad, Chief Medical Officer and Head of R&D; Dr. Steven Gray, Chief Scientific Adviser at Taysha and Associate Professor in the Department of Pediatrics at UT Southwestern; Kamran Alam, Chief Financial Officer; and Fred Porter, Chief Technical Officer, will join us for the question-and-answer session.
Earlier today, Taysha issued a press release announcing the acquisition of exclusive worldwide rights to TSHA-120 for the treatment of GAN,
Taysha Gene Therapies Inc GAN Program Acquisition Call Transcript
Apr 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers